Springworks Therapeutics Inc
(SWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 191,589 | 5,447 | 0 | 0 | 35,000 |
| Cost of Goods | 12,550 | 422 | N/A | N/A | N/A |
| Gross Profit | 179,039 | 5,025 | N/A | N/A | 35,000 |
| Operating Expenses | 457,720 | 348,460 | 280,674 | 173,468 | 81,324 |
| Operating Income | -278,131 | -343,013 | -280,674 | -173,468 | -46,324 |
| Other Income | 20,000 | 17,909 | 3,257 | -442 | 750 |
| Pre-tax Income | -258,131 | -325,104 | -277,417 | -173,910 | -45,574 |
| Net Income Continuous | -258,131 | -325,104 | -277,417 | -173,910 | -45,574 |
| Net Income | $-258,131 | $-325,104 | $-277,417 | $-173,910 | $-45,574 |
| EPS Basic Total Ops | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 |
| EPS Basic Continuous Ops | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 |
| EPS Diluted Total Ops | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 |
| EPS Diluted Continuous Ops | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 |
| EPS Diluted Before Non-Recurring Items | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 |
| EBITDA(a) | $-274,663 | $-341,346 | $-279,909 | $-172,978 | $-45,975 |